- Home
- YOU vs MRUS Comparison
YOU vs MRUS Comparison
Compare YOU & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- MRUS
- Stock Information
- Founded
- YOU 2010
- MRUS 2003
- Country
- YOU United States
- MRUS Netherlands
- Employees
- YOU N/A
- MRUS N/A
- Industry
- YOU Computer Software: Prepackaged Software
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- MRUS Health Care
- Exchange
- YOU Nasdaq
- MRUS Nasdaq
- Market Cap
- YOU 2.4B
- MRUS 2.7B
- IPO Year
- YOU 2021
- MRUS 2016
- Fundamental
- Price
- YOU $24.74
- MRUS $56.07
- Analyst Decision
- YOU Strong Buy
- MRUS Strong Buy
- Analyst Count
- YOU 4
- MRUS 15
- Target Price
- YOU $33.50
- MRUS $88.87
- AVG Volume (30 Days)
- YOU 2.1M
- MRUS 1.6M
- Earning Date
- YOU 05-08-2025
- MRUS 05-07-2025
- Dividend Yield
- YOU 3.01%
- MRUS N/A
- EPS Growth
- YOU 182.03
- MRUS N/A
- EPS
- YOU 1.59
- MRUS N/A
- Revenue
- YOU $802,807,000.00
- MRUS $54,732,000.00
- Revenue This Year
- YOU $14.77
- MRUS $39.00
- Revenue Next Year
- YOU $10.66
- MRUS $7.48
- P/E Ratio
- YOU $15.53
- MRUS N/A
- Revenue Growth
- YOU 21.59
- MRUS 42.77
- 52 Week Low
- YOU $16.59
- MRUS $33.19
- 52 Week High
- YOU $38.88
- MRUS $61.28
- Technical
- Relative Strength Index (RSI)
- YOU 48.20
- MRUS 66.86
- Support Level
- YOU $23.88
- MRUS $49.46
- Resistance Level
- YOU $25.63
- MRUS $56.74
- Average True Range (ATR)
- YOU 0.74
- MRUS 3.37
- MACD
- YOU -0.02
- MRUS 1.57
- Stochastic Oscillator
- YOU 49.14
- MRUS 91.31
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.